Quantification of nucleic acid quality in postmortem tissues from a cancer research autopsy program

Oncotarget

Volumn 7, Issue 41, 2016, Pages 66906-66921

  Fan, Jun ^a   Khanin, Raya ^a   Sakamoto, Hitomi ^a   Zhong, Yi ^a   Michael, Chelsea ^a   Pena, Derwin ^a   Javier, Breanna ^a   Wood, Laura D ^b   Iacobuzio Donahue, Christine A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autopsy; Metastasis; Post mortem; RNA; RNA sequencing

Indexed keywords

NUCLEIC ACID;

ARTICLE; AUTOPSY; CANCER RESEARCH; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; DNA DEGRADATION; GENE AMPLIFICATION; GENE LOCUS; GENETIC TRANSCRIPTION; HEART CANCER; HUMAN; HUMAN TISSUE; KIDNEY CANCER; LIVER CANCER; LIVER METASTASIS; LUNG CANCER; LUNG METASTASIS; MEDICAL PARAMETERS; MOLECULAR EVOLUTION; MUSCLE CANCER; NUCLEIC ACID QUALITY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; POLYMERASE CHAIN REACTION; POSTMORTEM INTERVAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; RNA DEGRADATION; RNA EXTRACTION; RNA INTEGRITY NUMBER; SKIN CANCER; SPLEEN CANCER; TISSUE DISTRIBUTION; CHEMISTRY; DNA DENATURATION; METABOLISM; NEOPLASM; PATHOLOGY; RNA STABILITY; STANDARDS;

AUTOPSY; HUMANS; NEOPLASMS; NUCLEIC ACID DENATURATION; NUCLEIC ACIDS; PATHOLOGY, CLINICAL; RNA STABILITY;

EID: 84994056512     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.11836     Document Type: Article

References (45)

1. Clark MJ. Autopsy. Lancet. 2005; 366:1767.
2. Scatliff JH, Morris PJ. From Roentgen to magnetic resonance imaging: the history of medical imaging. N C Med J. 2014; 75:111-113.
3. Burke MD. Laboratory medicine in the 21st Century. Am J Clin Pathol. 2000; 114:841-846.
4. Samarasekera N, Al-Shahi Salman R, Huitinga I, Klioueva N, McLean CA, Kretzschmar H, Smith C, Ironside JW. Brain banking for neurological disorders. Lancet Neurol. 2013; 12:1096-1105.
5. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Jr, Kinzler KW. Cancer genome landscapes. Science. 2013; 339:1546-1558.
6. Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science. 2011; 331:1553-1558.
7. Garraway LA, Lander ES. Lessons from the cancer genome. Cell. 2013; 153:17-37.
8. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, Sboner A, Esgueva R, Pflueger D, Sougnez C, Onofrio R, Carter SL, Park K, et al. The genomic complexity of primary human prostate cancer. Nature. 2011; 470:214-220.
9. Cancer Genome Atlas N. Genomic Classification of Cutaneous Melanoma. Cell. 2015; 161:1681-1696.
10. Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, Bowlby R, Shen H, Hayat S, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015; 163:506-519.
11. Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, Miller DK, Christ AN, Bruxner TJ, Quinn MC, Nourse C, Murtaugh LC, Harliwong I, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016; 531:47-52.
12. Bertotti A, Papp E, Jones S, Adleff V, Anagnostou V, Lupo B, Sausen M, Phallen J, Hruban CA, Tokheim C, Niknafs N, Nesselbush M, Lytle K, et al. The genomic landscape of response to EGFR blockade in colorectal cancer. Nature. 2015; 526:263-267.
13. Van Allen EM, Wagle N, Sucker A, Treacy DJ, Johannessen CM, Goetz EM, Place CS, Taylor-Weiner A, Whittaker S, Kryukov GV, Hodis E, Rosenberg M, McKenna A, et al. The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Cancer Discov. 2014; 4:94-109.
14. Juric D, Castel P, Griffith M, Griffith OL, Won HH, Ellis H, Ebbesen SH, Ainscough BJ, Ramu A, Iyer G, Shah RH, Huynh T, Mino-Kenudson M, et al. Convergent loss of PTEN leads to clinical resistance to a PI(3)Kalpha inhibitor. Nature. 2015; 518:240-244.
15. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010; 467:1114-1117.
16. Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, Chen L, Ewing CM, Eisenberger MA, Carducci MA, Nelson WG, Yegnasubramanian S, Luo J, et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med. 2009; 15:559-565.
17. Stan AD, Ghose S, Gao XM, Roberts RC, Lewis-Amezcua K, Hatanpaa KJ, Tamminga CA. Human postmortem tissue: what quality markers matter? Brain Res. 2006; 1123:1-11.
18. Hansen J, Lesnikova I, Funder AM, Banner J. DNA, RNA analysis of blood and muscle from bodies with variable postmortem intervals. Forensic Sci Med Pathol. 2014; 10:322-328.
19. van der Linden A, Blokker BM, Kap M, Weustink AC, Robertus JL, Riegman PH, Oosterhuis JW. Post-mortem tissue biopsies obtained at minimally invasive autopsy: an RNA-quality analysis. PLoS One. 2014; 9:e115675.
20. Carithers LJ, Ardlie K, Barcus M, Branton PA, Britton A, Buia SA, Compton CC, DeLuca DS, Peter-Demchok J, Gelfand ET, Guan P, Korzeniewski GE, Lockhart NC, et al. A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project. Biopreserv Biobank. 2015; 13:311-319.
21. Gupta S, Halushka MK, Hilton GM, Arking DE. Postmortem cardiac tissue maintains gene expression profile even after late harvesting. BMC Genomics. 2012; 13:26.
22. Gallego Romero I, Pai AA, Tung J, Gilad Y. RNA-seq: impact of RNA degradation on transcript quantification. BMC Biol. 2014; 12:42.
23. Kim BJ, Sprehe N, Morganti A, Wordinger RJ, Clark AF. The effect of postmortem time on the RNA quality of human ocular tissues. Mol Vis. 2013; 19:1290-1295.
24. Schoenberg DR, Maquat LE. Regulation of cytoplasmic mRNA decay. Nat Rev Genet. 2012; 13:246-259.
25. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, Frese KK, Denicola G, Feig C, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009; 324:1457-1461.
26. Shved N, Haas C, Papageorgopoulou C, Akguel G, Paulsen K, Bouwman A, Warinner C, Ruhli F. Post mortem DNA degradation of human tissue experimentally mummified in salt. PLoS One. 2014; 9:e110753.
27. Zhang P, Singh A, Yegnasubramanian S, Esopi D, Kombairaju P, Bodas M, Wu H, Bova SG, Biswal S. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol Cancer Ther. 2010; 9:336-346.
28. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol. 2003; 162:1151-1162.
29. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 2002; 62:2890-2896.
30. Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Baron A, Terris B, Jones M, Tyson K, Bassi C, Scarpa A, Lemoine NR. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene. 2001; 20: 7437-7446.
31. Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, Skinner HG, Goggins M, Jaffee EM, Yeo CJ, Cameron JL, Kern SE, et al. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res. 2001; 61:4320-4324.
32. Mehner C, Miller E, Nassar A, Bamlet WR, Radisky ES, Radisky DC. Tumor cell expression of MMP3 as a prognostic factor for poor survival in pancreatic, pulmonary, and mammary carcinoma. Genes Cancer. 2015; 6:480-489. doi: 10.18632/genesandcancer.90.
33. Ricci F, Kern SE, Hruban RH, Iacobuzio-Donahue CA. Stromal responses to carcinomas of the pancreas: juxtatumoral gene expression conforms to the infiltrating pattern and not the biologic subtype. Cancer Biol Ther. 2005; 4:302-307.
34. Wuebben EL, Wilder PJ, Cox JL, Grunkemeyer JA, Caffrey T, Hollingsworth MA, Rizzino A. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells. Oncotarget. 2016. doi: 10.18632/oncotarget.8994.
35. Babiceanu M, Qin F, Xie Z, Jia Y, Lopez K, Janus N, Facemire L, Kumar S, Pang Y, Qi Y, Lazar IM, Li H. Recurrent chimeric fusion RNAs in non-cancer tissues and cells. Nucleic Acids Res. 2016; 44:2859-2872.
36. Feng H, Zhang X, Zhang C. mRIN for direct assessment of genome-wide and gene-specific mRNA integrity from largescale RNA-sequencing data. Nat Commun. 2015; 6:7816.
37. Sigurgeirsson B, Emanuelsson O, Lundeberg J. Sequencing degraded RNA addressed by 3' tag counting. PLoS One. 2014; 9:e91851.
38. Sheedy D, Harding A, Say M, Stevens J, Kril JJ. Histological assessment of cerebellar granule cell layer in postmortem brain; a useful marker of tissue integrity? Cell Tissue Bank. 2012; 13:521-527.
39. Birdsill AC, Walker DG, Lue L, Sue LI, Beach TG. Postmortem interval effect on RNA and gene expression in human brain tissue. Cell Tissue Bank. 2011; 12:311-318.
40. Koppelkamm A, Vennemann B, Lutz-Bonengel S, Fracasso T, Vennemann M. RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays. Int J Legal Med. 2011; 125:573-580.
41. Walker DG, Whetzel AM, Serrano G, Sue LI, Lue LF, Beach TG. Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy program. Cell Tissue Bank. 2016.
42. Embuscado EE, Laheru D, Ricci F, Yun KJ, de Boom Witzel S, Seigel A, Flickinger K, Hidalgo M, Bova GS, Iacobuzio-Donahue CA. Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy. Cancer Biol Ther. 2005; 4:548-554.
43. Alaeddini R, Walsh SJ, Abbas A. Forensic implications of genetic analyses from degraded DNA-a review. Forensic Sci Int Genet. 2010; 4:148-157.
44. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013; 29:15-21.
45. Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010; 11:R106.